Sign-up for more details including this 2-page comparison PDF. 

You might also be interested in our 20% discount on new HRAs.

Click here for more details.

Eruptr logo

Copyright © 2022 Medicom Health LLC  •  All rights reserved.


Check out this client- requested alternative to our standard Breast Cancer Risk Assessment

We think many health systems will prefer this more modern approach, but the older one will remain available.

Complete the form for in-depth information.

Medicom Health converts web visits to care visits! Over 1,300 hospitals trust our service line-specific HRAs to engage millions of patients each year. Many customization, automation & mar-tech integration options are available. No outsourced development and we’re HITRUST certified.
Contact us today for a quick demo!

Eruptr elped pioneer search marketing for healthcare and continues to lead the industry today with a full suite of digital marketing services delivered to 70+ influential health systems representing over 200 hospitals and clinics.
Visit their website for more information.

This new Breast Cancer Screening assessment uses a lighter-weight consumer-oriented questionnaire on genetic factors with limited family history questions.

The primary result is a recommendation to seek genetic or imaging-based breast cancer screening (if needed) as based on a combination the newer FHS-7 and USPSTF algorithms.

These action-oriented results require less interpretation than percentages or categories. The 5-page report includes a lot of other tailored messaging including new content for people with LCIS, DCIS, known genetic markers and previous breast cancer.

A Quick Comparison of Our TwoBreast Cancer Assessments

NEW FOR 2022


New Breast Cancer Assessment